INTEGRATIVE DISSECTION OF GERMLINE GENOMIC FEATURES DRIVING CANCER RISK, DISEASE PROGRESSION, AND RESPONSE TO THERAPY IN PROSTATE CANCER
$1,327,499FY2021Defense Health AgencyDOD
Dana-Farber Cancer Institute, Inc.
Investigators
View source on USAspending →INTEGRATIVE DISSECTION OF GERMLINE GENOMIC FEATURES DRIVING CANCER RISK, DISEASE PROGRESSION, AND RESPONSE TO THERAPY IN PROSTATE CANCER · GrantIndex